Stay updated on Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedDifference0.1%

- Check18 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed. This appears to be a minor software version update with no visible changes to the study details.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded a Show glossary option and updated the Study Record Dates to display 'Last Update Submitted that Met QC Criteria'. The page footer now includes 'No FEAR Act Data' and a new 'Revision: v3.4.0' note.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3; this is a minor system update that does not affect the study content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedFooter shows Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.3.1. This is a minor UI/metadata update and does not affect the study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.